Efficacy After Dose Reduction
| Before dose reduction | 6 months after dose reduction | |
|---|---|---|
| (N=60) | (N=53) | |
| ACR20 response rate, n (%) | 49 (81.7) | 43 (81.1) |
| ΔHAQ-DI, mean (SD) | -0.7 (0.6) | -0.8 (0.7) |
| ΔDAS28-CRP, mean (SD) | -3.0 (1.2) | -3.0 (1.3) |
| ΔCDAI, mean (SD) | -28.4 (12.5) | -28.6 (14.6) |